ChemoCentryx's PIPE Round

ChemoCentryx raised a round of funding on September 18, 2018. Investors include Vifor Pharma.

ChemoCentryx (NASDAQ:CCXI) is a biopharmaceutical company focused on discovering, developing and commercializing orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders a…

Articles about ChemoCentryx's PIPE Round: